Market access and payer communications
Health Care Economic Information Under FDAMA 114 Guidance
FDA finally clarified how drugmakers can share cost data with insurers and formulary committees.
By David Osei-Bonsu
Tuesday, October 6, 2026Market access and payer communications
Market access and payer communications
Budget Impact Model Presentation Standards for Payer Audiences
ISPOR and ICER standards now jointly determine what budget impact analyses payers will accept.
Market access and payer communications
Patient Assistance Program Communication Compliance for Brand Teams
Recent rulings narrow brand teams' legal defenses for patient assistance program involvement.
Market access and payer communications
Medicaid Managed Care Plan Engagement Strategy for Drug Brands
Drug brands must navigate three hidden layers—MCO, PBM, and formulary—to reach Medicaid patients.
Market access and payer communications
Real-World Evidence Use in Payer-Facing Drug Promotional Materials
Payers want real-world evidence but lack the expertise and frameworks to evaluate it fairly.
Market access and payer communications
Budget Impact Model Presentation Standards for Payer Audiences
ISPOR and ICER standards now jointly determine what budget impact analyses payers will accept.
Patient Assistance Program Communication Compliance for Brand Teams
Recent rulings narrow brand teams' legal defenses for patient assistance program involvement.
Medicaid Managed Care Plan Engagement Strategy for Drug Brands
Drug brands must navigate three hidden layers—MCO, PBM, and formulary—to reach Medicaid patients.
Real-World Evidence Use in Payer-Facing Drug Promotional Materials
Payers want real-world evidence but lack the expertise and frameworks to evaluate it fairly.